momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (3343)	10/20/2005 8:23:09 PM
From: Ian@SI	Read Replies (1) of 12215

Rick, found another one for you... ;-) This sounds like an interesting approach. I trust Harmon's First Law Against Cancer Vaccines still applies. +++++++++++++ Public Release: 20-Oct-2005 Nature Medicine Rapid restoration of immunity in immune-suppressed cancer patients using T-cell vaccines Researchers at the University of Pennsylvania School of Medicine found that protective levels of immunity against pneumococcus could be obtained in immune-suppressed myeloma patients who were given a prophylactic bacterial vaccine in addition to a new autologous T-cell-based vaccine only two weeks after their stem-cell transplantation. They will apply the principles learned from this study to hone the development of a cancer vaccine aimed directly at tumors and other cancers. Leukemia and Lymphoma Society, NIH/National Institute of Allergy and Infectious Diseases, NIH/National Cancer Institute, Multiple Myeloma Research Foundation Whole story at: eurekalert.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next